These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

579 related items for PubMed ID: 24836068

  • 21. In silico, theoretical biointerface analysis and in vitro kinetic analysis of amine compounds interaction with acetylcholinesterase and butyrylcholinesterase.
    Kandasamy S, Loganathan C, Sakayanathan P, Karthikeyan S, Stephen AD, Marimuthu DK, Ravichandran S, Sivalingam V, Thayumanavan P.
    Int J Biol Macromol; 2021 Aug 31; 185():750-760. PubMed ID: 34216669
    [Abstract] [Full Text] [Related]

  • 22. Synthesis, molecular docking and biological evaluation of N,N-disubstituted 2-aminothiazolines as a new class of butyrylcholinesterase and carboxylesterase inhibitors.
    Makhaeva GF, Boltneva NP, Lushchekina SV, Serebryakova OG, Stupina TS, Terentiev AA, Serkov IV, Proshin AN, Bachurin SO, Richardson RJ.
    Bioorg Med Chem; 2016 Mar 01; 24(5):1050-62. PubMed ID: 26827140
    [Abstract] [Full Text] [Related]

  • 23. Synthesis and Hybrid SAR Property Modeling of Novel Cholinesterase Inhibitors.
    Kos J, Kozik V, Pindjakova D, Jankech T, Smolinski A, Stepankova S, Hosek J, Oravec M, Jampilek J, Bak A.
    Int J Mol Sci; 2021 Mar 26; 22(7):. PubMed ID: 33810550
    [Abstract] [Full Text] [Related]

  • 24. 9-Substituted acridine derivatives as acetylcholinesterase and butyrylcholinesterase inhibitors possessing antioxidant activity for Alzheimer's disease treatment.
    Makhaeva GF, Lushchekina SV, Boltneva NP, Serebryakova OG, Rudakova EV, Ustyugov AA, Bachurin SO, Shchepochkin AV, Chupakhin ON, Charushin VN, Richardson RJ.
    Bioorg Med Chem; 2017 Nov 01; 25(21):5981-5994. PubMed ID: 28986116
    [Abstract] [Full Text] [Related]

  • 25. Indolinone-based acetylcholinesterase inhibitors: synthesis, biological activity and molecular modeling.
    Akrami H, Mirjalili BF, Khoobi M, Nadri H, Moradi A, Sakhteman A, Emami S, Foroumadi A, Shafiee A.
    Eur J Med Chem; 2014 Sep 12; 84():375-81. PubMed ID: 25036795
    [Abstract] [Full Text] [Related]

  • 26. In-vitro evaluation and in-silico studies applied on newly synthesized amide derivatives of N-phthaloylglycine as Butyrylcholinesterase (BChE) inhibitors.
    Begum S, Nizami SS, Mahmood U, Masood S, Iftikhar S, Saied S.
    Comput Biol Chem; 2018 Jun 12; 74():212-217. PubMed ID: 29653432
    [Abstract] [Full Text] [Related]

  • 27. Highly functionalized 2-amino-4H-pyrans as potent cholinesterase inhibitors.
    Kumar RS, Almansour AI, Arumugam N, Al-Thamili DM, Basiri A, Kotresha D, Manohar TS, Venketesh S, Asad M, Asiri AM.
    Bioorg Chem; 2018 Dec 12; 81():134-143. PubMed ID: 30121001
    [Abstract] [Full Text] [Related]

  • 28. QSAR, docking, dynamic simulation and quantum mechanics studies to explore the recognition properties of cholinesterase binding sites.
    Correa-Basurto J, Bello M, Rosales-Hernández MC, Hernández-Rodríguez M, Nicolás-Vázquez I, Rojo-Domínguez A, Trujillo-Ferrara JG, Miranda R, Flores-Sandoval CA.
    Chem Biol Interact; 2014 Feb 25; 209():1-13. PubMed ID: 24321698
    [Abstract] [Full Text] [Related]

  • 29. Synthesis of novel 6-substituted-3(2H)-pyridazinone-2-acetyl-2-(substituted/-nonsubstituted benzal)hydrazone derivatives and acetylcholinesterase and butyrylcholinesterase inhibitory activities in vitro.
    Utku S, Gökçe M, Orhan I, Sahin MF.
    Arzneimittelforschung; 2011 Feb 25; 61(1):1-7. PubMed ID: 21355440
    [Abstract] [Full Text] [Related]

  • 30. 1,2,3,4-Tetrahydrobenzo[h][1,6]naphthyridines as a new family of potent peripheral-to-midgorge-site inhibitors of acetylcholinesterase: synthesis, pharmacological evaluation and mechanistic studies.
    Di Pietro O, Viayna E, Vicente-García E, Bartolini M, Ramón R, Juárez-Jiménez J, Clos MV, Pérez B, Andrisano V, Luque FJ, Lavilla R, Muñoz-Torrero D.
    Eur J Med Chem; 2014 Feb 12; 73():141-52. PubMed ID: 24389509
    [Abstract] [Full Text] [Related]

  • 31. Molecular-docking-guided design and synthesis of new IAA-tacrine hybrids as multifunctional AChE/BChE inhibitors.
    Cheng ZQ, Zhu KK, Zhang J, Song JL, Muehlmann LA, Jiang CS, Liu CL, Zhang H.
    Bioorg Chem; 2019 Mar 12; 83():277-288. PubMed ID: 30391700
    [Abstract] [Full Text] [Related]

  • 32. Cyclic acyl guanidines bearing carbamate moieties allow potent and dirigible cholinesterase inhibition of either acetyl- or butyrylcholinesterase.
    Darras FH, Kling B, Sawatzky E, Heilmann J, Decker M.
    Bioorg Med Chem; 2014 Sep 01; 22(17):5020-34. PubMed ID: 25059502
    [Abstract] [Full Text] [Related]

  • 33. New piperidine-hydrazone derivatives: Synthesis, biological evaluations and molecular docking studies as AChE and BChE inhibitors.
    Karaman N, Sıcak Y, Taşkın-Tok T, Öztürk M, Karaküçük-İyidoğan A, Dikmen M, Koçyiğit-Kaymakçıoğlu B, Oruç-Emre EE.
    Eur J Med Chem; 2016 Nov 29; 124():270-283. PubMed ID: 27592396
    [Abstract] [Full Text] [Related]

  • 34. Synthesis, in vitro assay, and molecular modeling of new piperidine derivatives having dual inhibitory potency against acetylcholinesterase and Abeta1-42 aggregation for Alzheimer's disease therapeutics.
    Kwon YE, Park JY, No KT, Shin JH, Lee SK, Eun JS, Yang JH, Shin TY, Kim DK, Chae BS, Leem JY, Kim KH.
    Bioorg Med Chem; 2007 Oct 15; 15(20):6596-607. PubMed ID: 17681794
    [Abstract] [Full Text] [Related]

  • 35. Ionic liquid-enabled synthesis, cholinesterase inhibitory activity, and molecular docking study of highly functionalized tetrasubstituted pyrrolidines.
    Kumar RS, Almansour AI, Arumugam N, Althomili DMQ, Altaf M, Basiri A, D K, Sai Manohar T, S V.
    Bioorg Chem; 2018 Apr 15; 77():263-268. PubMed ID: 29421701
    [Abstract] [Full Text] [Related]

  • 36. Novel ferulic amide derivatives with tertiary amine side chain as acetylcholinesterase and butyrylcholinesterase inhibitors: The influence of carbon spacer length, alkylamine and aromatic group.
    Liu H, Liu L, Gao X, Liu Y, Xu W, He W, Jiang H, Tang J, Fan H, Xia X.
    Eur J Med Chem; 2017 Jan 27; 126():810-822. PubMed ID: 27951489
    [Abstract] [Full Text] [Related]

  • 37. Docking and quantum mechanic studies on cholinesterases and their inhibitors.
    Correa-Basurto J, Flores-Sandoval C, Marín-Cruz J, Rojo-Domínguez A, Espinoza-Fonseca LM, Trujillo-Ferrara JG.
    Eur J Med Chem; 2007 Jan 27; 42(1):10-9. PubMed ID: 17055616
    [Abstract] [Full Text] [Related]

  • 38. Synthesis, structure-activity relationship and molecular docking of 3-oxoaurones and 3-thioaurones as acetylcholinesterase and butyrylcholinesterase inhibitors.
    Mughal EU, Sadiq A, Murtaza S, Rafique H, Zafar MN, Riaz T, Khan BA, Hameed A, Khan KM.
    Bioorg Med Chem; 2017 Jan 01; 25(1):100-106. PubMed ID: 27780618
    [Abstract] [Full Text] [Related]

  • 39. Pyridine sulfonamide as a small key organic molecule for the potential treatment of type-II diabetes mellitus and Alzheimer's disease: In vitro studies against yeast α-glucosidase, acetylcholinesterase and butyrylcholinesterase.
    Riaz S, Khan IU, Bajda M, Ashraf M, Qurat-Ul-Ain, Shaukat A, Rehman TU, Mutahir S, Hussain S, Mustafa G, Yar M.
    Bioorg Chem; 2015 Dec 01; 63():64-71. PubMed ID: 26451651
    [Abstract] [Full Text] [Related]

  • 40. Synthesis, preliminarily biological evaluation and molecular docking study of new Olaparib analogues as multifunctional PARP-1 and cholinesterase inhibitors.
    Gao CZ, Dong W, Cui ZW, Yuan Q, Hu XM, Wu QM, Han X, Xu Y, Min ZL.
    J Enzyme Inhib Med Chem; 2019 Dec 01; 34(1):150-162. PubMed ID: 30427217
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 29.